Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain

May 19, 2022 updated by: Juan Martínez Fuentes, Universidad Católica San Antonio de Murcia

Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain: A Randomized Clinical Trial

Non-specific low back pain can be caused by the presence of active trigger points in the muscles of the lumbopelvic region. Trigger points are defined as hypersensitive points within a taut band of a musculoskeletal system that cause pain during contraction, stretching, or stimulation of said muscle. If these points are active, they can trigger referred pain, local tenderness, and vegetative responses. There is scientific evidence of the improvement of the treatment of these points through non-invasive manual techniques. The objective of this study will be to determine the effect of Strain Counterstrain and Myofascial Induction techniques in subjects with low back pain secondary to the presence of active trigger points in the lumbopelvic region. Hyperexcitable myofascial trigger points located within a taut band of skeletal muscle or fascia cause referred pain, local tenderness, and autonomic changes. The scientific data refer to an immediate improvement in the symptoms of these active points treated with manual therapy. Based on these factors, the objective of the study is to determine the effect of the combined therapy of the Strain Counterstrain technique and Myofascial Induction in participants with the presence of an active trigger point in the erector spinae muscle.

Study Overview

Detailed Description

The treatment will last a total of 15 minutes accompanied by a baseline assessment and after 10 minutes of the intervention in 2 experimental groups and a placebo group, of no-pain positioning. In addition to basic indices and scales of low back pain and disability caused by low back pain, it is intended to measure flexibility, range of motion, proprioception and cognition through software with sensors of the latest technology when representing reliable results in differences between techniques.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Murcia, Spain, 30107
        • Universidad Católica de Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Presence of low back pain
  • Presence of active trigger point in the erector spinae as described by Lawrence H. Jones

Exclusion Criteria:

  • Participants who present dizziness, vertigo;
  • Previous or scheduled surgeries in the lumbar spine and/or lower extremities;
  • Suspicion of serious fractures or pathologies (tumor, inflammation, infection, rheumatological disorder, systemic disease, presence of fever);
  • Diagnosis of radiculopathy or neuropathy;
  • Structural deformity in the spine; spondyloarthropathy, disabling pain and physical disability;
  • Use of pain relievers or anti-inflammatory drugs in the last 48 hours;
  • Neurological or psychiatric disorder;
  • Presence or suspicion of pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Jones Group (Strain Counterstrain)
Jones Group consist in 90 seconds in a ralease positioning of no pain in muscle acortation
No pain positioning technique with diaphragmatic breathing
Active Comparator: Myofascial Induction Group
Myofascial Induction Group consist in 15 minutes of superficial and deep lumbar fascia maneuvers
Myofascial Induction technique on the lumbar fascia
Placebo Comparator: Placebo Group
Placebo Group only have to mantain no pain positioning for 3 minutes
No pain positioning of participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: 20 minutes
Measured with Numeric Rating Scale wich consist in measure pain intensity with a score of 0-10
20 minutes
Pression algometer
Time Frame: 20 minutes
Measures pressure pain thresholds
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal test
Time Frame: 20 minutes
Measured with Baiobit Software. The range of movement will be measured in grades as per: flexion/extension; right/left rotation; and right/left inclination
20 minutes
Countermovement jump test
Time Frame: 20 minutes
Measured with Baiobit software counter movement jump test wich consist a velocity, height and accuracy evaluation of a vertical jump
20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2022

Primary Completion (Actual)

March 23, 2022

Study Completion (Actual)

May 19, 2022

Study Registration Dates

First Submitted

February 7, 2022

First Submitted That Met QC Criteria

March 14, 2022

First Posted (Actual)

March 15, 2022

Study Record Updates

Last Update Posted (Actual)

May 20, 2022

Last Update Submitted That Met QC Criteria

May 19, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Jones Group (Strain Counterstrain)

3
Subscribe